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College, Buffalo, New YorkABSTRACT Agonists, including the neurotransmitter acetylcholine (ACh), bind at two sites in the neuromuscular ACh receptor
channel (AChR) to promote a reversible, global change in protein conformation that regulates the flow of ions across the muscle
cell membrane. In the synaptic cleft, ACh is hydrolyzed to acetate and choline. Replacement of the transmitter’s ester acetyl
group with a hydroxyl (ACh/choline) results in a þ1.8 kcal/mol reduction in the energy for gating generated by each agonist
molecule from a low- to high-affinity change of the transmitter binding site (DGB). To understand the distinct actions of structur-
ally related agonist molecules, we measured DGB for 10 related choline derivatives. Replacing the hydroxyl group of choline with
different substituents, such as hydrogen, chloride, methyl, or amine, increased the energy for gating (i.e., it made DGB more
negative relative to choline). Extending the ethyl hydroxide tail of choline to propyl and butyl hydroxide also increased this
energy. Our findings reveal the amount of energy that is available for the AChR conformational change provided by different,
structurally related agonists. We speculate that a hydrogen bond between the choline hydroxyl and the backbone carbonyl of
aW149 positions this agonist’s quaternary ammonium group so as to reduce the cation-p interaction between this moiety
and the aromatic groups at the binding site.INTRODUCTIONNicotinic acetylcholine receptor channels (AChRs) mediate
fast chemical transmissions between nerve and muscle. This
membrane protein undergoes a global allosteric gating tran-
sition between a low-affinity/closed-channel structure and
a high-affinity/open-channel structure (C4O), both with
and without ligands present at its two transmitter binding
sites (1–4). Agonist molecules, including the neurotrans-
mitter acetylcholine (ACh), bind with a low affinity to two
target sites in the protein that can switch to a higher-affinity
conformation. As a consequence, when agonists are present
at the binding sites, the probability of being in the open
conformation (Po) increases, and cations enter and depo-
larize the muscle cell, which eventually may contract.
Many different ligands can activate AChRs, but to dif-
ferent maximum extents. ACh is able to open transiently
neuromuscular AChRs nearly completely (Po
max ~ 0.96).
In the synaptic cleft, free ACh is hydrolyzed by acetylcho-
linesterase to acetate and choline, which has a hydroxyl
group in place of the neurotransmitter’s ester acetyl group.
This molecular replacement decreases the diliganded gating
equilibrium constant (E2) by ~550-fold (5–8), so synaptic
choline hardly activates these AChRs (Po
max ~ 0.05).
Here, we seek to understand the nature of the atomic inter-
actions that determine the extent to which a bound ligand
activates AChRs.
As a member of the pentameric ligand-gated ion channel
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0006-3495/13/02/0565/10 $2.00homologous subunits (a12bdε) that fold into covalently
linked extracellular and transmembrane domains (9). The
channel’s gate region is located in the central pore of the
transmembrane domain, and the two transmitter binding
sites are in the extracellular domain at the a-d and a-ε
subunit interfaces. X-ray structures of AChR homologs
bound with ligand (10–13) and mutational analyses (14–
18) have revealed that the agonist’s quaternary ammonium
group is surrounded by a cluster of aromatic residues,
mostly in the a subunit.
The magnitudes of E2 and Po
max are determined by the
amount of binding energy contributed by the agonist mole-
cule toward the full C4O gating isomerization. This
energy, DGB, is equal to the difference in binding energy,
i.e., high versus low affinity (to O versus to C; Fig. S1 in
the Supporting Material). Our approach was to measure
DGB for a variety of related choline derivatives to explore
which aspects of the ligand’s structure correlate with the
energy it provides to gating in adult mouse neuromuscular
AChRs with wild-type (WT) binding sites. Specifically, we
hoped to identify atoms of the agonist that are responsible
for setting DGB. For ACh, the source of DGB energy is
mainly interactions of its cation moiety with three aromatic
groups in the a subunit (19), by cation-p forces (20). Many
different agonists (including choline) have quaternary
ammonium groups, and we wondered why some of these
provide less energy for gating compared with ACh.
One can estimate DGB experimentally by invoking a
cyclic model for activation (Fig. S1) (21,22). The two
adult-type AChR transmitter binding sites provide approxi-
mately equal energies for both ACh and choline (23).http://dx.doi.org/10.1016/j.bpj.2012.11.3833
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equilibrium constants with two versus without any agonists
(E2/E0) is equal to the ratio of the C versus O equilibrium
dissociation constants squared (Kd/Jd)
2. E2 is estimated for
each agonist as the ratio of the diliganded opening versus
the closing rate constants (E2 ¼ f2/b2), which in turn are
measured from interval durations of single-channel currents
obtained at high agonist concentrations. The energy (in
kcal/mol) provided by the affinity change for the agonist
at each site is DGB ¼ 0.59 ln(Kd/Jd), or, equivalently
2DGB ¼ 0:59 ln

E2
E0

(1)
TheWTunliganded gating equilibrium constant at100mV
is E0 ¼ 7  107 (2,3,23). Because this value is agonist
independent, to estimate DGB, all we need to measure is
the ratio of rate constants, f2/b2, for each ligand.
Substantial evidence indicates that there are one or more
brief intermediate states between the C and O ground states
(8,24–27). For a sequence of reactions, the net energy
difference between the end states is equal to the sum of
the energy changes of all of the intermediate transitions.
The experimental E2 and DGB values we report below
pertain to the complete transition between diliganded C
and O. Our measurements do not distinguish at which
point(s) in the gating sequence the energy from the affinity
change is realized.
Most agonists are cations that can block the channel pore
(Fig. S2). When the channel-blocked state is brief, the
single-channel current amplitude decreases, which makes
it difficult to measure interval durations using high agonist
concentrations. By depolarizing the membrane and using
background mutations that compensate for the effect of
depolarization on E2, it is possible to measure precisely
the interval durations without the interference from channel
block (5). These experiments show that ACh, tetramethy-
lammonium (TMA), and choline provide an average of
DGB ¼ 5.1, 4.5, and 3.3 kcal/mol/ligand toward the
gating isomerization, respectively. Here we attempt to ratio-
nalize these energy differences based on ligand and protein
structures.
We measured DGB for 10 choline derivatives. Our find-
ings reveal the amount of energy that is available for the
AChR conformational change provided by these ligands.MATERIALS AND METHODS
Mutagenesis and expression
Mutant cDNAs of the mouse AChR a and ε subunits listed in Table S1 and
Table S2 were created using the QuikChange Site-Directed Mutagenesis
Kit (Stratagene) and confirmed by dideoxy sequencing. HEK 293 cells
were transiently transfected with WT and mutant subunit cDNAs by
calcium phosphate precipitation. Approximately 3.5 mg of AChR a, b, d,
and ε subunit DNAwas added to each 35-mm culture dish in a 2:1:1:1 ratio,Biophysical Journal 104(3) 565–574along with cDNA for green fluorescent protein (GFP), as a transfection
marker. After ~16 h of incubation at 37C, the cells were washed with fresh
culture medium.Electrophysiology and kinetic analysis
Single-channel currents were recorded at 23C in a cell-attached configura-
tion within ~48 h post-transfection. The bath solution contained (in mM)
142 KCl, 5.4 NaCl, 1.8 CaCl2, 1.7 MgCl2, 10 HEPES/KOH (pH 7.4).
The pipettes were filled with agonist diluted with Dulbecco’s phosphate-
buffered saline containing (in mM) 137 NaCl, 0.9 CaCl2, 2.7 KCl,
1.5 KH2PO4, 0.5 MgCl2, and 8.1 Na2HPO4 (pH 7.4). To reduce channel
block by the agonist, the pipette potential (Vp ¼ Vmembrane) was held at
100 mV (Fig. S2), except for experiments with betaine, which is not
a channel blocker (Vp ¼ þ100 mV).
In experiments with cholamine (pKa ¼ 7.1), the HEPES buffer was
replaced with 50 mM TABS (N-tris(hydroxymethyl)methyl-4-aminobuta-
nesulfonic acid) or 50 mM MOPSO (3-morpholino-2-hydroxypropanesul-
fonic acid) to achieve a pH of 9.0 or 6.1, respectively. Using these
buffers at pH 6.1 or 9.0 did not affect the E2
choline estimate. The primary
amine of cholamine is 91% in the protonated, charged form at pH 6.1,
and 99% deprotonated at pH 9.0 (28). A saturating concentration of chol-
amine (at pH 6.1 and 9.0) was reached at ~5 mM.
Single-channel currents were filtered at 20 kHz and digitized at a
sampling frequency of 50 kHz. Kinetic analyses were performed with the
use of QuB software (http://www.qub.buffalo.edu). Currents from clusters
of openings (Fig. 1 A) were idealized into noise-free interval durations
with the SKM algorithm. The interval durations were fitted by a reaction
scheme that had a gating step (A2C4A2O, where A is the agonist) and
another step representing occasional sojourns entry in a nonconducting,
presumably desensitized state attached to A2O (29). The diliganded forward
(f2) and backward (b2) gating rate constants were estimated from the ideal-
ized intracluster interval durations obtained at a saturating agonist concen-
tration by means of a maximum-interval likelihood algorithm (Table S1).
Saturation was defined as the concentration of agonist that elicited the
maximum f2 value (the apparent f2 did not change with a further increase
in concentration). To assess saturation, f2 was measured at agonist con-
centrations of (at least) 50, 100, and 140 mM. The diliganded gating
equilibrium constant was calculated as E2 ¼ f2/b2. A 2-fold change in E2
translates to a ~0.2 kcal/mol difference in DGB, which is approximately
our resolution limit.
To allow greater accuracy in the measurements, we used background
mutations to generate f2 and b2 values that were in an easily measurable
range (5). The effects of these substitutions, both alone and in combina-
tion, were previously calibrated and shown to change E0 but have no
effect on the affinity ratio. From the cycle, E2 ¼ E0(Kd/Jd)2, so adding
perturbations that change only E0 result in an equivalent change in E2,
which is what we measured. Rather than struggle with quantifying
single-channel current intervals that were either too brief for accurate
rate constant estimation or too long-lived to allow clear cluster definition,
we added mutations simply to adjust E0 to produce interval durations
that were well within the time resolution of our equipment, software, and
analysis protocols. With this engineering approach, we were able to mea-
sure the experimental gating rate constants accurately and then calculate
what E2 would have been under a reference condition (100 mV, 23C,
adult WT mouse AChRs).
For example, consider the results for the agonist BTMA (Table S1). The
measurements were obtained at þ100 mVand with two background muta-
tions, aS450W and aD97I. These three perturbations each change E0 by
factors of 0.08, 9.9, and 0.4, respectively (Table S2). It was previously
established that the effects of these specific perturbations are independent
of each other and of DGB (5). Together, these three perturbations increase
E0 (and E2) by (0.08)(9.9)(0.4) ¼ 0.32-fold (5,19). The experimentally
observed E2 for BTMA on this background was 0.78, so the E2 value we
calculate for the reference condition is 0.78/0.32 ¼ 2.44.
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FIGURE 1 Estimating DGB from single-channel
currents. The agonist was 3OH-PTMA. (A) At low
time resolution, openings (up; Vm¼þ100 mV) are
clustered. Within a cluster, a single AChR switches
repeatedly between C and O; between clusters, all
AChRs in the patch are desensitized. (B) Higher-
time-resolution view of clusters at different levels
of [3OH-PTMA]. (C) The effective opening rate
(inverse intracluster shut time) increases with
increasing [3OH-PTMA] to reach an asymptote
at >20 mM, signifying binding-site saturation.
(D) Closed and open interval duration histograms
at 100 mM [3OH-PTMA]. At Vm ¼ þ100 mV
and with the εS450A background mutation, the
measured f2 and b2 were 564 s
1 and 2764 s1,
respectively (E2¼ 0.20). These background pertur-
bations combined increase E0 (and hence E2) by
1.36-fold, so the corrected E2 value (100 mV,
WT) is 0.15 (Table S1 and Table S2). From
Eq. 1, for 3OH-PTMA, DGB ¼ 3.6 kcal/mol.
Energy for gating from different AChR agonists 567In some cases, other or additional loss- or gain-of-function background
mutants (aD97A, aD97N, aD97I, aY127F, aS269I, and εL269F) were
used to decrease or increase the opening rate constants to allow cluster
formation and DGB measurements of high- and low-efficacy agonists
(Table S2) (30–35). Again, these mutations were all previously shown to
change only E0 (independently) and not DGB. As described above, we
divided the observed E2 value by the net fold change of the background
construct to estimate the E2 value at the reference condition. Both the
observed and background-corrected E2 values are given in Table S1.
The intrinsic gating equilibrium constant at Vm ¼ 100 mV is E0 ¼ 7 
107 (2,3). If the two binding sites are equivalent, then the energy that an
agonist provides toward gating is given by Eq. 1. So far, this has been shown
to be the case only for ACh and choline (23), but we assumed that this
was also true for the other agonists. The coupling free energy of perturba-
tion cycle analysis was calculated as DGB
mod1&2/(DGB
mod1  DGB mod2),
where mod represents an agonist modification such as tail elongation or
addition of a hydroxyl. The error limits (SEM) for DGB were calculated
as described elsewhere (19).
We use the term ‘‘gating’’ to refer to the complete, C4O allosteric tran-
sition rather than the ultimate molecular movement that allows water and
ions to cross the membrane. Within the C4O gating isomerization, the
AChR passes through brief intermediate states. Such sojourns were too
short-lived to be detected as discrete intervals in our experiments. However,
this does not affect the DGB estimates. Our energy measurements are based
on E0, E2, and the thermodynamic cycle. Given a sequential gating scheme
with explicit intermediate states, these experimental equilibrium constants
are just the products of all of the microscopic ones across the sequence. Our
objective was to estimate the total energy difference between the A2C
and A2O ground states, and the presence of intermediate states between
these two positions along the gating reaction coordinate is not relevant to
that goal.Homology modeling
Molecular modeling was performed using the ZMM program (http://www.
zmmsoft.com), which employs the Monte Carlo minimization algorithm
(MCM) to search for energetically favorable conformations (36). Atom-
atom interactions were calculated using the AMBER force field (37). A
cutoff distance of 8 A˚ was used for nonbonded interactions. Electrostatic
interactions were calculated using a distant- and solvent-exposure-depen-
dent dielectric function (38). Hydration energy was calculated using the
implicit-solvent method (39). An explicit water molecule was initially con-strained to the backbone oxygen of dN109 and backbone nitrogen of dL121.
In subsequent MCM trajectories the constraints were removed, but the
water molecule did not move away from these residues. This explicit water
was suggested to be important for ACh binding (40), but we found that it
was not important for the binding of TMA and choline. Ionizable residues
of the protein were treated as neutral (39). The atomic charges of ligands
were calculated by the AM1 method (41) using the MOPAC program
(http://www.mopac.com). Bond angles of the ligand were allowed to vary
in energy minimizations.
Our model of the mouse muscle AChR included the a and d subunits of
the extracellular domain, which were built according to the X-ray structure
of Aplysia california ACh binding protein (AChBP) bound with epibatidine
(PDB code 2BYQ (11)). The extracellular domain of the neuromuscular
AChR a1 subunit has a sequence similarity of 64% with the A. californica
AChBP versus 59% with Lymnaea stagnalis. The sequences of AChBP and
AChR were aligned as shown in Table S3. The AChR transmembrane
domain and the AChR loop insertions of the extracellular domain, which
are not present in AChBP, were not modeled. The homology model was
MC-minimized until 2000 consecutive energy minimizations did not
decrease the energy of the apparent global minimum found. During energy
minimizations, the a carbons of the protein were constrained to the tem-
plate structure by pins, which are flat-bottom energy constraints that allow
atoms to deviate penalty-free up to 1 A˚ from the template, and impose a
penalty of 10 kcal/mol/A˚ for larger deviations.
We searched for the optimal positions and orientations of choline and
TMA using a multi-MCM protocol (42,43). First, we generated 20,000
random starting points of the ligand within a cube of 7 A˚ in length. The
size of the cube covered the transmitter binding site. Each starting point
was optimized in an MCM trajectory of five steps to remove steric overlaps
with the protein. Two hundred lowest-energy structures found at this stage
were further MC-minimized in longer trajectories to refine the protein-
ligand complexes. These trajectories were terminated after 1000 con-
secutive steps did not improve the best minimum found. The 10 best
ligand-receptor complexes were analyzed. Although no specific energy
terms were used for p-cation interactions, these interactions were ac-
counted for by partial negative charges at the aromatic carbons (44).Chemical synthesis
Six choline derivatives were synthesized because they were commercially
unavailable as quaternary salts or their salt forms were unsuitable for elec-
trophysiology experiments with an Ag-AgCl electrode. Tertiary aminesBiophysical Journal 104(3) 565–574
568 Bruhova et al.were quaternized using methyl tosylate to prepare 3-hydroxypropyltrime-
thylammonium tosylate, 2-hydroxypropyltrimethylammonium tosylate,
4-hydroxybutyltrimethylammonium tosylate, and butyltrimethylammo-
nium tosylate. Trimethylamine was alkylated to produce ethyltrimethylam-
monium bromide and propyltrimethylammonium bromide. For further
details about the quaternization of amines, see the Supporting Material.RESULTS
Choline has a quaternary ammonium group and a hydroxyl
group connected by an ethyl linker. We refer to the carbon to
which the hydroxyl group is attached to as C2. We investi-
gated three sets of choline derivatives by 1), extending the
hydroxyethyl tail of choline to hydroxypropyl and hydroxy-
butyl; 2), extending the alkyl tail of TMA (without the
hydroxyl group) from methyl to ethyl, propyl, and butyl;
and 3), substituting the hydroxyl group at C2 with different
functional groups. We chemically synthesized six of the
choline derivatives using alkylation techniques as described
in the Supporting Material.
Fig. 1 shows single-channel currents from AChRs
activated by 3-hydroxypropyltrimethylammonium (3OH-
PTMA) at a membrane potential of þ100 mV. At
100 mV, this agonist blocks the channel and reduces the
current amplitude. To avoid this problem, we depolarized
the membrane to þ100 mV and effectively eliminated
such a fast channel block. Accordingly, the (outward)
single-channel current amplitude was 4.3 pA in the presence
of 100 mM 3OH-PTMA (Fig. 1 B, top). The effective
opening rate constant (f2) increased with increasing concen-
trations of the ligand to reach a plateau at ~20 mM, which
demonstrates that at this concentration the binding sites
were fully occupied by agonist molecules (Fig. 1 C). After
correcting for the background perturbations, we estimate
E2 ¼ 0.15 for 3OH-PTMA (100 mV, WT AChRs). WeTABLE 1 Energy estimates for choline derivatives
Ligand E2 5 SE
ACh, acetylcholine 25.40
Set 1: Extending the alkyl tail of TMA
TMA, tetramethylammonium 2.54b
ETMA, ethyltrimethylammoniumc 0.255 0
PTMA, propyltrimethylammoniumc 0.295 0
BTMA, butyltrimethylammoniumd 2.445 0
Set 2: Extending the hydroxyethyl tail of choline
Choline,2-hydroxyethyltrimethylammonium 0.05b
3OH-PTMA, 3-hydroxypropyltrimethylammoniumc 0.155 0
4OH-BTMA, 4-hydroxybutyltrimethylammoniumc 0.715 0
Set 3: Substitutions at carbon#2 position
ClCho, 2-chloroethyltrimethylammonium 0.195 0
2OH-PTMA, 2-hydroxypropyltrimethylammoniume 0.025 0
Cholamine (pH 9.0), 2-aminoethyltrimethylammoniume 0.045 0
Cholamine (pH 6.1), 2-aminoethyltrimethylammoniumf 0.00125
Betaine, 2-aminoethanoic acid or trimethylglycineg 1.6E-55 9
E2 values were corrected for the following background constructs:
c
εS450A, dεS
See Table S1 for the uncorrected values and Table S2 for the effects of the bac
aDGB ¼ 0.59$ln[O(E2/E0)].
bPreviously published E2 measurements (5).
Biophysical Journal 104(3) 565–574calculate (Eq. 1) that this agonist provides DGB ¼
3.6 kcal/mol/ligand for gating (Table 1). 3OH-PTMA
provides 1.5 kcal/mol less favorable energy for gating
than ACh, but 0.3 kcal/mol more favorable energy than
choline.Extending the ethyl tail of choline with or without
a hydroxyl group
We first examined ligands with a quaternary ammonium
group and various tail lengths, with and without a terminal
hydroxyl group. These derivatives were ethyltrimethylam-
monium (ETMA), propyltrimethylammonium (PTMA),
3-hydroxypropyltrimethylammonium (3OH-PTMA), butyl-
trimethylammonium (BTMA), and 4-hydroxybutyltrime-
thylammonium (4OH-BTMA) (Fig. 2, A and B).
Choline and ETMA, which have the same tail length,
provided the least favorable binding energy for gating
from this group of agonists (Table 1). A longer tail resulted
in more favorable (more negative) binding energies (Fig. 2
A). However, this apparent pattern did not apply to TMA,
which is one methylene shorter than choline but provides
only slightly less energy than does ACh. DGB for TMA
is ~0.7 kcal/mol more favorable than for ETMA and
~1.2 kcal/mol more favorable than for choline. The order
of binding energy with respect to tail length was as follows:
ethylz propyl < butylz methyl.
When we compared derivatives with or without a
hydroxyl group, we found that in all cases, those without the
hydroxyl provided more favorable energy (Fig. 2, A and B;
Table 1). The hydroxyl group had an unfavorable effect
(made DGB more positive) of þ0.5 kcal/mol (ETMAversus
choline), þ0.2 kcal/mol (PTMA versus 3OH-PTMA),
and þ0.4 kcal/mol (BMTA versus 4OH-BTMA).M O(E2/E0)5 SEM DGB
a 5 SEM, (kcal/mol)
b 6024 5.1
1905 4.5
.11 5975 136 3.85 0.1
.13 6445 143 3.85 0.1
.18 18675 116 4.45 0.03
256 3.3
.03 4645 54 3.65 0.1
.34 10105 248 4.15 0.1
.12 5235 160 3.75 0.2
.01 1705 34 3.05 0.1
.01 2435 33 3.25 0.1
0.001 425 23 2.25 0.3
.3E-6 4.75 1.4 0.95 0.2
450WþaD97I, eεL269F, fεL269FþaD97N, and ga(D97AþY127þS269I).
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FIGURE 2 Binding energies and chemical struc-
tures of three sets of choline derivatives. (A)
Extending the hydroxyethyl tail of choline to
hydroxypropyl and hydroxybutyl (TMA shown
for comparison). (B) Extending the alkyl tail of
TMA from methyl to ethyl, propyl, or butyl.
(C) Substituting the hydroxyl group of choline at
C2 with different functional groups. Ligands with
H-bonding ability are weaker agonists.
Energy for gating from different AChR agonists 569Considering the above ligands, choline provided the least
energy for gating because it possesses both of the unfavor-
able characteristics (i.e., an ethyl tail length and a hydroxyl
group).Substitutions at C2 position
Fig. 2C compares the binding energies of choline derivatives
having different substitutions at C2. The hydroxyl of choline
was substituted with a chloride (chlorocholine), hydrogen
(ETMA), methyl (PTMA), amine (cholamine at pH 9.0),
ammonium (cholamine at pH 6.1), a hydroxyl and methyl
(2OH-PTMA; 2-hydroxypropyltrimethylammonium), or
carboxylic acid (betaine, also called trimethylglycine).
Compared with choline, four of these seven substitutions
reduced the binding energy, by 0.1–2.4 kcal/mol. The order
of effect was as follows: amine > hydroxyl and methyl >
ammonium > carboxylic acid. Three of the substitutions
at C2 provided a more negative DGB energy than choline.
Chloride, hydrogen, or a methyl group made DGB more
negative compared with choline, by ~0.5 kcal/mol. A differ-
ence between the two groups of derivatives, which either
decrease or increase the energy from the affinity change,
is their H-bonding ability. The derivatives that readily
H-bond had a less favorable DGB than those without
H-bonding ability.
Betaine deserves special mention because it is a physio-
logical ligand (the oxidation product of choline) and
because it is the only agonist that we have studied so farthat provides substantially less binding energy than choline.
Betaine is a zwitterion and is neutral at pH 7 and has a posi-
tive charge at the quaternary ammonium center and a nega-
tive charge at the carboxylic group. This agonist provides
only ~0.9 kcal/mol toward gating. It is still an agonist,
but is so weak as to be nearly a pure antagonist. Betaine
binds with almost equal affinities to the C and O conforma-
tions, and therefore hardly promotes the gating isomeriza-
tion. We did not measure the affinity of the resting AChR
for betaine, so we do not know whether this ligand is an
antagonist under physiological conditions.F analysis
The opening rate constant versus the gating equilibrium
constant (Table S1) for the choline derivatives is plotted
on a log-log scale in Fig. 3. The slope of the linear fit of
this rate-equilibrium relationship is called F, which esti-
mates the relative timing of the energy change of the binding
site’s affinity change in the gating isomerization of the
protein. A F-value of one suggests an earlier energy change
event, whereas zero suggests a later event. Plotting the
results for all of the agonists, including ACh, TMA, and
water (no ligand) (3), we estimate Fagonist ¼ 0.90 5 0.02
(r2¼ 0.996), which is similar to values previously estimated
for more traditional agonists (0.93 in Grosman et al. (45)).
The correlation was the same for all ligands, including
water, over a >10 million-fold range in gating equilibrium
constant.Biophysical Journal 104(3) 565–574
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FIGURE 3 Rate-equilibrium analysis of choline derivatives. On a log-log
scale, the opening rate constant (f2) is plotted against the gating equilibrium
constant (E2). The slope of the linear fit (F) was 0.905 0.02. The agonists
in this plot are (from top to bottom) ACh, TMA, BTMA, 4OH-BMTA,
PTMA, ETMA, ClCho, 3OH-PTMA, cholamine pH 9.0, Cho, 2OH-
PTMA, cholamine pH 6.1, betaine, and water (no added ligand).
570 Bruhova et al.Homology model of AChR with TMA or choline
To further understand the binding energy estimates, we
turned to molecular modeling. We used the x-ray structure
of A. californica AChBP (11) to build a homology model
of the AChR transmitter binding site. We randomly sampled
20,000 orientations of TMA or choline in the AChBP-based
model of AChR (Fig. 4 A; Table S3), which after multi-MC-
minimization yielded 10 most-favorable complexes.
The 10 most favorable binding modes of choline and
TMA are shown in Fig. 4, C and D. As expected, the ammo-
nium group of the agonist was positioned between aromatic
residues of the a subunit. The largest stabilizing contribu-
tions to agonist binding were from aW149, aY190, and
aY198 (Table S4). In agreement with electrophysiology
experiments (19), the computations show that this aromatic
triad provides most of the total ligand-receptor energy.
Weaker binding energies were from aY93, dW57, and
dL121, each of which interacts with the agonist by <10%
of the total ligand-receptor energy.
Among the energetically most favorable modes, the posi-
tion of the quaternary ammonium group of choline did not
deviate much; however, the agonist tail did adopt a variety
of orientations. In most of the favorable modes, choline’s
hydroxyl formed an H-bond with the backbone oxygen of
aW149, which in effect slightly altered the position of its
ammonium group compared with that of TMA, with respect
to the aromatic groups of aW149 and aY190 (Fig. 4 E). In
particular, the ammonium group of TMA is closer to the
indole ring of aW149 compared with that of choline. This
is in agreement with our structure-activity studies, which
showed that removal of the hydroxyl group produces more
active compounds. We hypothesize that this backbone-
hydroxyl H-bond causes, in part, the more-positive DGB
for choline relative to TMA.Biophysical Journal 104(3) 565–574The modeling also shows that the aY93 side chain is in
different orientations with TMA versus choline because of
a rotation about the Ca-Cb bond. This aromatic group
provides little energy for gating by ACh (Table S4 (19), so
we do not think that this structural variation is important
with regard to DGB for TMA versus choline.DISCUSSION
Measuring agonist structure-activity relationships has long
been a core experimental approach in pharmacology. For
neuromuscular AChRs, the activity part of this relation-
ship has been measured at increasingly mechanistic levels,
from muscle contraction to membrane potential, membrane
current, gating equilibrium constant, and now, energy from
the affinity change. In the experiments reported here, the
binding site was WT, and hence the DGB and E2 values
had a fixed relation (Eq. 1). However, the method we used
allows for DGB measurements in AChRs with mutations
of binding-site amino acids, in which case E0 may not be
the same as in the WT (46). This approach allows the struc-
ture part of the relationship to be expanded to include both
the agonist and groups of the protein with which it interacts
(19). In our view, DGB is the appropriate quantitative index
to use to rank the activity of agonists (Fig. 2).
E2 values for some partial agonists of adult-type mouse
neuromuscular AChRs with WT binding sites have been re-
ported previously (5,8,26,45,47–51). We chose to investi-
gate other partial agonists, particularly choline derivatives,
because technical advances have made it possible to obtain
more accurate estimates of DGB. Specifically, we can 1),
separate measurements of the gating rate constants without
contamination from channel block and desensitization (5);
2), measure the energy (DGB) contributed by the affinity
change for the agonist because the value of the intrinsic
gating equilibrium constant (E0) is known (2,3); and 3),
engineer predictable AChR gating rate constants to measure
E2 accurately for high-efficacy or low-efficacy agonists (5).
Each choline provides 3.3 kcal/mol for gating from the
affinity change, compared with 5.1 kcal/mol for ACh and
4.5 kcal/mol for TMA. One of our goals was to identify
the structures and interactions that are responsible for
the þ1.2 kcal/mol energy difference between choline and
TMA. We selected choline derivatives that differed by
only one or a few atoms. Our approach was to identify the
specific atoms that could increase or decrease DGB relative
to choline. For example, elongating the alkyl tail by
one -CH2- (PTMA versus BTMA) makes DGB more nega-
tive by 0.6 kcal/mol, and replacing the terminal -H
with -OH (ETMAversus choline) makes DGB more positive
by þ0.5 kcal/mol.
We can ask whether these two kinds of substitutions
have energetically independent consequences. Fig. 5 shows
a perturbation cycle analysis, which suggests that these
substitutions are almost independent, so we conclude that
BδW57
αW149
αY198
αY190
αY93
δL121
δW57
αW149
αY198
αY190
αY93
δL121
E
C D
A
δW57
αW149αY198
αY190
αY93
δL121
αW149
αY198
αY190
FIGURE 4 AChBP-based homology model of
the AChR transmitter binding site with TMA and
choline. (A) 1000 of the 10,000 randomly sampled
orientations and positions of choline within the
AChR transmitter binding site. The backbones of
the a and d subunits are presented as smooth
ribbons. The ligand is shown in wireframe format,
but its ammonium group is shown as a dark ball.
(B) X-ray structure of Lymnaea AChBP bound
with carbamylcholine (PDB accession number
1uv6). The aromatic triad is in green (AChR
numbering). (C) The 10 most favorable binding
modes of choline. Only residues within 4 A˚ from
the ligand are shown as sticks. For clarity, the back-
bone atoms of the highlighted residues are not
shown, except for aW149 and dL121. In six of
the 10 modes, there is an H-bond between the
choline hydroxyl and the backbone carbonyl of
aW149. (D) The 10 most favorable binding modes
of TMA. (E) Comparison of favorable binding
modes of choline versus TMA. The relative posi-
tion of the quaternary ammonium group within
the aromatic triad (aW149, aY190, and aY198)
is different for these two agonists. Although
aY93 adopts alternative rotamers in TMA versus
choline, this aromatic group likely contributes little
to DGB.
Energy for gating from different AChR agonists 571it is the tail methyl group of BTMA that provides the
0.6 kcal/mol toward gating, rather than a wholesale
change in the location of the ligand within the binding
pocket. With this dissection, we estimate that for choline,
C2 makes DGB more positive by þ0.7 kcal/mol (TMA
versus ETMA) and the hydroxyl makes DGB more positive
by þ0.5 kcal/mol (ETMA versus choline). Choline is a
particular low-efficacy agonist among this group because
it has two structural elements, each of which indepen-
dently reduces the energy from the affinity change by
~þ0.6 kcal/mol.
The F value for the agonists we examined was ~0.9,
which is consistent with previous measurements for other
ligands. F gives the relative point in the reaction when the
perturbed structural element changes energy. The high
F-value for all of these agonists suggests that with WT
binding sites, the affinity change occurs relatively early in
the forward gating isomerization, which likely proceedsthrough a sequence of one or more intermediate microstates.
However, it is important to emphasize that the ligand need
not be the first structural element to change energy in gating.
For example, residues near the C-terminus of the aM2
helix (the M2-cap) have F-values of ~1, suggesting that
this region of the protein changes energy at the same time
(or before) the binding sites in the forward isomerization.
Also, the F-values of some binding-site residues that
contribute to the affinity ratio are lower in unliganded versus
diliganded gating (19). The agonist has no momentum, so
there is no a priori reason to assume that channel opening
begins with the affinity-change/binding-site rearrangement,
or indeed at any other particular place in the protein. Despite
the high F-values that have been measured so far for
agonists and binding-site residues, it is possible that the
mechanical work of the channel-opening conformational
change initiates at some region other than the transmitter
binding sites.Biophysical Journal 104(3) 565–574
ETMA -3.8 kcal/mol Choline -3.3
PTMA -3.8
BTMA -4.5 4OH-BTMA -4.1
Coupling
-0.3 kcal/mol
Coupling
0.2 kcal/mol
-0.3-0.05
-0.6
+0.4
-0.5
Addition of OH group
E
longation of alkyl tail
Coupling of outer cycle
-0.1 kcal/mol
N+
OH
N+
OHN+N+
OHN
+N+
+0.2
+0.5
3OH-PTMA -3.6
FIGURE 5 Perturbation-cycle analysis of choline derivatives. Addition
of an OH group (horizontal arrows) and elongation of the alkyl tail (vertical
arrows) are weakly coupled (by <0.3 kcal/mol), and thus the substitutions
are nearly independent and additive. This suggests that these ligands bind
similarly, and hence that DGB differences can be attributed to specific
atoms.
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AChR agonists forms cation-p interactions with aromatic
residues located in the subunit interface. The benzene/indole
rings of the aromatic triad, which is comprised of aW149,
aY190, and aY198, provide the majority of the DGB energy
(~2 kcal/mol/ring) for ACh (19). ACh, TMA, and choline
each possess a quaternary ammonium, but their DGB values
vary substantially. We considered the extents to which the
DGB differences between agonists might arise from differ-
ences in their intrinsic cation-p binding strengths or in their
positions within the aromatic field.
The strength of a cation-p interaction is influenced by an
electrostatic force between the cation and the quadrupole
moment of the aromatic ring (20). The receptor provides
Tyr and Trp aromatic rings, and the agonist provides a
positively charged ammonium group. Ab initio calculations
predict that the intrinsic cation-p ability of both the
aromatic groups and the agonist ammonium group varies,
in the order Trp>TyrzPhe (52) and TMA>ETMA>TEMA
(triethylmethylammonium), with the difference between
TMA and ETMA calculated to be ~þ0.3 kcal/mol (49).
This value is less than our observed difference of
þ0.7 kcal/mol. Partial charge calculations using MOPAC
show that the quaternary ammonium group (C4H11N) of
ACh is only slightly more positive (þ0.94) than choline
(þ0.87), a difference that is probably too small to account
for the experimental DGB difference between these ligands.Biophysical Journal 104(3) 565–574It appears that the experimental DGB differences cannot be
attributed to the intrinsic properties of the agonist’s quater-
nary ammonium group.
An H-bond acceptor four or five bonds removed from
the ammonium group was found to be a critical determinant
for longer agonists, such as ACh, carbamylcholine, nicotine,
and epibatidine (40). As seen in the x-ray structure of
AChBP bound with nicotine (PDB code 1UW6 (10)), the
H-bond acceptor of the agonist forms an H-bond with
a structural water molecule interacting with the backbone
of L102 and M114 (in AChBP numbering) of the comple-
mentary side. Thus, some larger agonists are stabilized by
both a cation-p interaction with the aromatic triad and
also by an energetically favorable H-bond with the com-
plementary subunit. Shorter agonists, such as TMA and
choline, do not possess this H-bond acceptor and therefore
do not have this additional, favorable interaction with the
protein.
TMA provides 0.6 kcal/mol less favorable binding energy
than ACh, and 1.2 kcal/mol more favorable binding energy
than choline. The structure-activity relationships show that
a hydroxyl at carbon 2 or 3, or an amine at carbon 2 (within
three bonds away from the agonist ammonium group) is
unfavorable. In our AChR homology model, choline adopts
an energetically unfavorable binding mode by H-bonding
with the backbone carbonyl of aW149. A comparison of
the choline and TMA binding modes reveals that the loca-
tion of the quaternary ammonium group relative to the
aW149 and aY190 side chains is displaced (Fig. 4 E). We
hypothesize that the H-bond donor of choline forms an
interaction with the backbone carbonyl of aW149, which
alters the position of the quaternary ammonium group to
reduce the strength of the cation-p interaction with the
aW149 indole and the aY190 and aY198 benzene elements
of the triad (Table S4). This would explain why choline,
cholamine, 2OH-PTMA, and 3OH-PTMA are less effica-
cious than the other choline derivatives, such as TMA,
chlorocholine, 4OH-BTMA, ETMA, PTMA, and BTMA,
which would not H-bond with the backbone of aW149.
In summary, the relatively small DGB from choline can be
attributed to a combination of interactions at C2 and the
hydroxyl group. We hypothesize that the hydroxyl group
forms an H-bond with the aW149 backbone carbonyl,
which serves to position the quaternary ammonium group
within the aromatic residues of the binding site so as to
reduce cation-p forces relative to agonists that do not
form this H-bond. This hypothesis predicts that the ligand
stabilization energy from the aromatic groups should be
smaller for choline than for TMA and ACh. However,
because the unfavorable interaction of choline is with a
backbone atom, it does not shed light on the possibility
that neuromuscular AChRs evolved to derive different
binding energies for the transmitter versus its breakdown
product. Further experimental analyses of choline and its
derivatives using AChRs with binding-site mutations may
Energy for gating from different AChR agonists 573reveal the full complement of the sources of energy for
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